303 related articles for article (PubMed ID: 26919324)
1. Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients.
Castro-Sesquen YE; Gilman RH; Mejia C; Clark DE; Choi J; Reimer-McAtee MJ; Castro R; Valencia-Ayala E; Flores J; Bowman N; Castillo-Neyra R; Torrico F; Liotta L; Bern C; Luchini A;
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004407. PubMed ID: 26919324
[TBL] [Abstract][Full Text] [Related]
2. Use of a novel chagas urine nanoparticle test (chunap) for diagnosis of congenital chagas disease.
Castro-Sesquen YE; Gilman RH; Galdos-Cardenas G; Ferrufino L; Sánchez G; Valencia Ayala E; Liotta L; Bern C; Luchini A;
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3211. PubMed ID: 25275534
[TBL] [Abstract][Full Text] [Related]
3. Real-time PCR in HIV/Trypanosoma cruzi coinfection with and without Chagas disease reactivation: association with HIV viral load and CD4 level.
de Freitas VL; da Silva SC; Sartori AM; Bezerra RC; Westphalen EV; Molina TD; Teixeira AR; Ibrahim KY; Shikanai-Yasuda MA
PLoS Negl Trop Dis; 2011 Aug; 5(8):e1277. PubMed ID: 21912712
[TBL] [Abstract][Full Text] [Related]
4. HIV and Chagas Disease: An Evaluation of the Use of Real-Time Quantitative Polymerase Chain Reaction to Measure Levels of Trypanosoma cruzi Parasitemia in HIV Patients in Cochabamba, Bolivia.
Reimer-McAtee MJ; Mejia C; Clark T; Terle J; Pajuelo MJ; Cabeza J; Lora MH; Valencia E; Castro R; Lozano D; Bern C; Torrico F; Gilman RH
Am J Trop Med Hyg; 2021 Aug; 105(3):643-650. PubMed ID: 34398818
[TBL] [Abstract][Full Text] [Related]
5. Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection.
Freitas VLT; Novaes CTG; Sartori AMC; Carvalho NB; Silva SCVD; Nakanishi ÉS; Salvador F; Castro CN; Bezerra RC; Westphalen EVN; Oliveira CMR; Busser FD; Ho YL; Buccheri R; Bonilla C; Shikanai-Yasuda MA
PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011961. PubMed ID: 38408095
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi parasitemia in chronic Chagas disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients.
Sartori AM; Neto JE; Nunes EV; Braz LM; Caiaffa-Filho HH; Oliveira Oda C; Neto VA; Shikanai-Yasuda MA
J Infect Dis; 2002 Sep; 186(6):872-5. PubMed ID: 12198628
[TBL] [Abstract][Full Text] [Related]
7. Chagas disease and liver transplantation: Experience in Argentina using real-time quantitative PCR for early detection and treatment.
Balderramo D; Bonisconti F; Alcaraz A; Giordano E; Sánchez A; Barrabino M; Caeiro JP; Alvarellos T; Maraschio M
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28941300
[TBL] [Abstract][Full Text] [Related]
8. How to improve the early diagnosis of Trypanosoma cruzi infection: relationship between validated conventional diagnosis and quantitative DNA amplification in congenitally infected children.
Bua J; Volta BJ; Perrone AE; Scollo K; Velázquez EB; Ruiz AM; De Rissio AM; Cardoni RL
PLoS Negl Trop Dis; 2013; 7(10):e2476. PubMed ID: 24147166
[TBL] [Abstract][Full Text] [Related]
9. Development of a Novel Multiplex Immunoassay Multi-cruzi for the Serological Confirmation of Chagas Disease.
Granjon E; Dichtel-Danjoy ML; Saba E; Sabino E; Campos de Oliveira L; Zrein M
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004596. PubMed ID: 27035146
[TBL] [Abstract][Full Text] [Related]
10. A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients.
Zrein M; Granjon E; Gueyffier L; Caillaudeau J; Liehl P; Pottel H; Cardoso CS; Oliveira CDL; de Oliveira LC; Lee TH; Ferreira AM; Ribeiro ALP; Busch MP; Sabino EC
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006226. PubMed ID: 29425201
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of co-infected HIV and Trypanosoma cruzi Brazilian patients.
Da-Cruz AM; Igreja RP; Dantas W; Junqueira AC; Pacheco RS; Silva-Gonçalves AJ; Pirmez C
Trans R Soc Trop Med Hyg; 2004 Dec; 98(12):728-33. PubMed ID: 15485703
[TBL] [Abstract][Full Text] [Related]
12. Clinical and epidemiological features of chronic Trypanosoma cruzi infection in patients with HIV/AIDS in Buenos Aires, Argentina.
Benchetrit AG; Fernández M; Bava AJ; Corti M; Porteiro N; Martínez Peralta L
Int J Infect Dis; 2018 Feb; 67():118-121. PubMed ID: 29196277
[TBL] [Abstract][Full Text] [Related]
13. Parasitemia Levels in Trypanosoma cruzi Infection in Spain, an Area Where the Disease Is Not Endemic: Trends by Different Molecular Approaches.
Flores-Chavez MD; Abras A; Ballart C; Ibáñez-Perez I; Perez-Gordillo P; Gállego M; Muñoz C; Moure Z; Sulleiro E; Nieto J; García Diez E; Simón L; Cruz I; Picado A
Microbiol Spectr; 2022 Oct; 10(5):e0262822. PubMed ID: 36190410
[TBL] [Abstract][Full Text] [Related]
14. Cytokine serum levels in patients infected by human immunodeficiency virus with and without Trypanosoma cruzi coinfection.
Rodrigues DB; Correia D; Marra MD; Giraldo LE; Lages-Silva E; Silva-Vergara ML; Barata CH; Rodrigues Junior V
Rev Soc Bras Med Trop; 2005; 38(6):483-7. PubMed ID: 16410923
[TBL] [Abstract][Full Text] [Related]
15. Parasite load evaluation by qPCR and blood culture in Chagas disease and HIV co-infected patients under antiretroviral therapy.
Marcon GEB; Ferreira JJG; de Almeida EA; Delicio AM; Pereira MB; Wanderley JDS; Martins LC; Andrade PD; de Lima RG; Costa SCB
PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010317. PubMed ID: 35353834
[TBL] [Abstract][Full Text] [Related]
16. Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial.
Moreira OC; Ramírez JD; Velázquez E; Melo MF; Lima-Ferreira C; Guhl F; Sosa-Estani S; Marin-Neto JA; Morillo CA; Britto C
Acta Trop; 2013 Jan; 125(1):23-31. PubMed ID: 22982466
[TBL] [Abstract][Full Text] [Related]
17. IgG Autoantibodies Induced by T. cruzi During Pregnancy: Correlation with Gravidity Complications and Early Outcome Assessment of the Newborns.
Vicco MH; Rodeles L; Capovilla GS; Perrig M; Choque AG; Marcipar I; Bottasso O; Rodriguez C; Cuña W
Matern Child Health J; 2016 Oct; 20(10):2057-64. PubMed ID: 27318490
[TBL] [Abstract][Full Text] [Related]
18. Clinical analysis and parasite genetic diversity in human immunodeficiency virus/Chagas' disease coinfections in Brazil.
Perez-Ramirez L; Barnabé C; Sartori AM; Ferreira MS; Tolezano JE; Nunes EV; Burgarelli MK; Silva AC; Shikanai-Yasuda MA; Lima JN; Da-Cruz AM; Oliveira OC; Guilherme C; Bastrenta B; Tibayrenc M
Am J Trop Med Hyg; 1999 Aug; 61(2):198-206. PubMed ID: 10463667
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of congenital Trypanosoma cruzi infection: A serologic test using Shed Acute Phase Antigen (SAPA) in mother-child binomial samples.
Volta BJ; Russomando G; Bustos PL; Scollo K; De Rissio AM; Sánchez Z; Cardoni RL; Bua J
Acta Trop; 2015 Jul; 147():31-7. PubMed ID: 25847262
[TBL] [Abstract][Full Text] [Related]
20. Presence of IgM antibodies to Trypanosoma cruzi urinary antigen in sera from patients with acute Chagas' disease.
Corral RS; Altcheh JM; Freilij HL
Int J Parasitol; 1998 Apr; 28(4):589-94. PubMed ID: 9602379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
